nelfinavir has been researched along with Lipodystrophy in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, W; Caughey, B; Chung, C; Dai, Z; Hu, F; Lan, Y; Li, L; Tang, X; Zhang, K | 1 |
Carr, A; Chisholm, DJ; Cooper, DA; Gan, SK; Kraegen, EW; Samaras, K; Thompson, CH | 1 |
Ceccaldi, PF; Deleuze, J; Dimet, J; Dupin, N; Escande, JP; Gorin, I; Morini, JP; Pons, G; Rey, E; Tréluyer, JM | 1 |
Burton, S; Carr, A; Chisholm, DJ; Cooper, DA; Freund, J; Law, M; Samaras, K | 1 |
Ceballos, J; Iglesias, M; Ostrosky-Zeichner, L; Ponce-de-Leon, S | 1 |
Carver, PL; Cinti, SK; Kaul, DR; Kazanjian, PH | 1 |
Lewis, RH; Popescu, M | 1 |
Duncombe, C | 1 |
1 review(s) available for nelfinavir and Lipodystrophy
Article | Year |
---|---|
HIV protease inhibitors: advances in therapy and adverse reactions, including metabolic complications.
Topics: Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Indinavir; Lipodystrophy; Nelfinavir; Ritonavir; Saquinavir | 1999 |
1 trial(s) available for nelfinavir and Lipodystrophy
Article | Year |
---|---|
High concentrations of nelfinavir as an independent risk factor for lipodystrophy in human immunodeficiency virus-infected patients.
Topics: Body Composition; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lipodystrophy; Male; Middle Aged; Nelfinavir; Risk Factors | 2002 |
6 other study(ies) available for nelfinavir and Lipodystrophy
Article | Year |
---|---|
Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-infected Patients Treated with Highly Active Antiretroviral Therapy (HAART).
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; Case-Control Studies; Cyclopropanes; DNA, Mitochondrial; Drug Combinations; Female; HIV; HIV Infections; Humans; Lamivudine; Lipodystrophy; Lopinavir; Male; Middle Aged; Mitochondria; Nelfinavir; Predictive Value of Tests; Ritonavir; ROC Curve; Stavudine; Zidovudine | 2015 |
Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy.
Topics: Absorptiometry, Photon; Acquired Immunodeficiency Syndrome; Adipose Tissue; Adult; Anti-HIV Agents; Blood Glucose; Body Composition; HIV Protease Inhibitors; Homeostasis; Humans; Indinavir; Insulin; Leptin; Lipids; Lipodystrophy; Magnetic Resonance Imaging; Male; Middle Aged; Nelfinavir; Ritonavir; Saquinavir | 2002 |
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.
Topics: Adult; Anti-HIV Agents; Body Composition; Cross-Sectional Studies; Diabetes Mellitus; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Indinavir; Insulin Resistance; Lipodystrophy; Male; Nelfinavir; Risk Factors; Ritonavir; Saquinavir; Syndrome | 1998 |
Liposuction for protease-inhibitor-associated lipodystrophy.
Topics: HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lipectomy; Lipodystrophy; Male; Middle Aged; Nelfinavir; Saquinavir | 1999 |
Lipodystrophy: results of a data evaluation of patients receiving nelfinavir-containing combination therapy.
Topics: Anti-HIV Agents; Databases, Factual; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Incidence; Lipodystrophy; Nelfinavir; Retrospective Studies; Reverse Transcriptase Inhibitors | 2000 |
Reversal of hyperlipidemia and lipodystrophy in patients switching therapy to nelfinavir.
Topics: Anti-HIV Agents; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Hyperlipidemias; Lipodystrophy; Nelfinavir; Prospective Studies | 2000 |